HEADER TRANSFERASE/TRANSFERASE INHIBITOR 04-JAN-18 6C1C TITLE FGFR1 KINASE COMPLEX WITH INHIBITOR SN37116 COMPND MOL_ID: 1; COMPND 2 MOLECULE: FIBROBLAST GROWTH FACTOR RECEPTOR 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 457-763; COMPND 5 SYNONYM: FGFR-1,BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1,BFGF-R-1, COMPND 6 FMS-LIKE TYROSINE KINASE 2,FLT-2,N-SAM,PROTO-ONCOGENE C-FGR; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FGFR1, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Y.YOSAATMADJA,J.B.SMAILL,C.J.SQUIRE REVDAT 3 04-OCT-23 6C1C 1 REMARK REVDAT 2 01-JAN-20 6C1C 1 REMARK REVDAT 1 16-JAN-19 6C1C 0 JRNL AUTH Y.YOSAATMADJA,C.J.SQUIRE,A.V.PATTERSON,J.B.SMAILL JRNL TITL UNDERSTANDING THE STRUCTURAL REQUIREMENTS FOR COVALENT JRNL TITL 2 INHIBITION OF FGFR1-3 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0049 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.51 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 36092 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.228 REMARK 3 R VALUE (WORKING SET) : 0.226 REMARK 3 FREE R VALUE : 0.270 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1889 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.15 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.21 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2648 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.96 REMARK 3 BIN R VALUE (WORKING SET) : 0.3110 REMARK 3 BIN FREE R VALUE SET COUNT : 157 REMARK 3 BIN FREE R VALUE : 0.3380 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4155 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 91 REMARK 3 SOLVENT ATOMS : 54 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.59 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.44000 REMARK 3 B22 (A**2) : 1.43000 REMARK 3 B33 (A**2) : -0.61000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.42000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.239 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.206 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.179 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.118 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.945 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.917 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4398 ; 0.009 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): 4167 ; 0.003 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5979 ; 1.344 ; 2.003 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9592 ; 0.868 ; 3.006 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 546 ; 5.731 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 174 ;37.755 ;24.368 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 724 ;14.009 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 25 ;15.901 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 669 ; 0.081 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4888 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 913 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2193 ; 2.342 ; 4.339 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2192 ; 2.342 ; 4.338 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2733 ; 3.690 ; 6.480 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2734 ; 3.689 ; 6.481 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2205 ; 2.338 ; 4.449 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2202 ; 2.334 ; 4.440 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 3240 ; 3.733 ; 6.598 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 4860 ; 5.255 ;33.310 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 4848 ; 5.248 ;33.310 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 6C1C COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-JAN-18. REMARK 100 THE DEPOSITION ID IS D_1000231929. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-DEC-14 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.95370 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37994 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.150 REMARK 200 RESOLUTION RANGE LOW (A) : 19.510 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 7.500 REMARK 200 R MERGE (I) : 0.08700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.22 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4WUN REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.35 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.48 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% MPEG 5000, 0.1 M SODIUM CACODYLATE REMARK 280 PH 7.5, 0.2 M AMMONIUM SULFATE, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 106.64650 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 26.01750 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 106.64650 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 26.01750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 455 REMARK 465 ALA A 456 REMARK 465 MET A 457 REMARK 465 SER A 458 REMARK 465 GLY A 459 REMARK 465 VAL A 460 REMARK 465 SER A 461 REMARK 465 GLU A 462 REMARK 465 TYR A 463 REMARK 465 GLU A 464 REMARK 465 GLY A 487 REMARK 465 ALA A 488 REMARK 465 PHE A 489 REMARK 465 GLY A 580 REMARK 465 LEU A 581 REMARK 465 GLU A 582 REMARK 465 TYR A 583 REMARK 465 ALA A 645 REMARK 465 ARG A 646 REMARK 465 ASP A 647 REMARK 465 ILE A 648 REMARK 465 HIS A 649 REMARK 465 HIS A 650 REMARK 465 ILE A 651 REMARK 465 ASP A 652 REMARK 465 TYR A 653 REMARK 465 TYR A 654 REMARK 465 LYS A 655 REMARK 465 LYS A 656 REMARK 465 THR A 657 REMARK 465 THR A 658 REMARK 465 ASN A 659 REMARK 465 GLY A 660 REMARK 465 ARG A 661 REMARK 465 LEU A 662 REMARK 465 GLY B 455 REMARK 465 ALA B 456 REMARK 465 MET B 457 REMARK 465 SER B 458 REMARK 465 GLY B 459 REMARK 465 VAL B 460 REMARK 465 SER B 461 REMARK 465 GLU B 462 REMARK 465 ALA B 488 REMARK 465 LYS B 502 REMARK 465 ASP B 503 REMARK 465 PRO B 579 REMARK 465 GLY B 580 REMARK 465 LEU B 581 REMARK 465 GLU B 582 REMARK 465 TYR B 583 REMARK 465 SER B 584 REMARK 465 TYR B 585 REMARK 465 ASN B 586 REMARK 465 PRO B 587 REMARK 465 SER B 588 REMARK 465 HIS B 589 REMARK 465 ASN B 590 REMARK 465 PRO B 591 REMARK 465 GLU B 592 REMARK 465 GLU B 593 REMARK 465 ARG B 646 REMARK 465 ASP B 647 REMARK 465 ILE B 648 REMARK 465 HIS B 649 REMARK 465 HIS B 650 REMARK 465 ILE B 651 REMARK 465 ASP B 652 REMARK 465 TYR B 653 REMARK 465 TYR B 654 REMARK 465 LYS B 655 REMARK 465 LYS B 656 REMARK 465 THR B 657 REMARK 465 THR B 658 REMARK 465 ASN B 659 REMARK 465 GLY B 660 REMARK 465 ARG B 661 REMARK 465 GLN B 764 REMARK 465 GLU B 765 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 465 CG CD1 CD2 REMARK 470 GLU A 486 CG CD OE1 OE2 REMARK 470 LYS A 502 CG CD CE NZ REMARK 470 LYS A 504 CG CD CE NZ REMARK 470 ARG A 507 CG CD NE CZ NH1 NH2 REMARK 470 LEU A 516 CG CD1 CD2 REMARK 470 LYS A 517 CG CD CE NZ REMARK 470 SER A 518 OG REMARK 470 ASP A 519 CG OD1 OD2 REMARK 470 GLU A 522 CG CD OE1 OE2 REMARK 470 LYS A 523 CG CD CE NZ REMARK 470 ASP A 554 CG OD1 OD2 REMARK 470 HIS A 589 CG ND1 CD2 CE1 NE2 REMARK 470 ASN A 590 CG OD1 ND2 REMARK 470 GLN A 594 CG CD OE1 NE2 REMARK 470 PHE A 673 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG A 675 CG CD NE CZ NH1 NH2 REMARK 470 PHE A 710 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 711 CG CD CE NZ REMARK 470 LYS A 714 CG CD CE NZ REMARK 470 ASN A 763 CG OD1 ND2 REMARK 470 GLU B 464 CG CD OE1 OE2 REMARK 470 ARG B 477 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 486 CG CD OE1 OE2 REMARK 470 ASP B 501 CG OD1 OD2 REMARK 470 LYS B 504 CG CD CE NZ REMARK 470 ASN B 506 CG OD1 ND2 REMARK 470 ARG B 507 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 517 CD CE NZ REMARK 470 GLU B 522 CG CD OE1 OE2 REMARK 470 LYS B 523 CE NZ REMARK 470 GLN B 594 CG CD OE1 NE2 REMARK 470 LYS B 618 CG CD CE NZ REMARK 470 LEU B 662 CG CD1 CD2 REMARK 470 LEU B 672 CG CD1 CD2 REMARK 470 PHE B 673 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ASP B 674 CG OD1 OD2 REMARK 470 ARG B 675 CG CD NE CZ NH1 NH2 REMARK 470 ILE B 676 CG1 CG2 CD1 REMARK 470 LYS B 711 CG CD CE NZ REMARK 470 LYS B 714 CG CD CE NZ REMARK 470 ASN B 763 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 519 63.55 -103.34 REMARK 500 GLN A 553 -73.97 -100.40 REMARK 500 ASP A 554 32.93 -72.67 REMARK 500 ASN A 590 77.01 -110.68 REMARK 500 ARG A 622 -21.26 87.89 REMARK 500 ASP A 623 48.61 -142.83 REMARK 500 ARG B 622 -22.94 84.75 REMARK 500 ASP B 623 43.11 -140.94 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue YY6 A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue YY6 B 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 802 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6C18 RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH THE RELATED INHIBITOR REMARK 900 RELATED ID: 6C19 RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH THE RELATED INHIBITOR REMARK 900 RELATED ID: 6C1B RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH RELATED INHIBITOR DBREF 6C1C A 459 765 UNP P11362 FGFR1_HUMAN 457 763 DBREF 6C1C B 459 765 UNP P11362 FGFR1_HUMAN 457 763 SEQADV 6C1C GLY A 455 UNP P11362 EXPRESSION TAG SEQADV 6C1C ALA A 456 UNP P11362 EXPRESSION TAG SEQADV 6C1C MET A 457 UNP P11362 EXPRESSION TAG SEQADV 6C1C SER A 458 UNP P11362 EXPRESSION TAG SEQADV 6C1C ALA A 488 UNP P11362 CYS 486 ENGINEERED MUTATION SEQADV 6C1C SER A 584 UNP P11362 CYS 582 ENGINEERED MUTATION SEQADV 6C1C GLY B 455 UNP P11362 EXPRESSION TAG SEQADV 6C1C ALA B 456 UNP P11362 EXPRESSION TAG SEQADV 6C1C MET B 457 UNP P11362 EXPRESSION TAG SEQADV 6C1C SER B 458 UNP P11362 EXPRESSION TAG SEQADV 6C1C ALA B 488 UNP P11362 CYS 486 ENGINEERED MUTATION SEQADV 6C1C SER B 584 UNP P11362 CYS 582 ENGINEERED MUTATION SEQRES 1 A 311 GLY ALA MET SER GLY VAL SER GLU TYR GLU LEU PRO GLU SEQRES 2 A 311 ASP PRO ARG TRP GLU LEU PRO ARG ASP ARG LEU VAL LEU SEQRES 3 A 311 GLY LYS PRO LEU GLY GLU GLY ALA PHE GLY GLN VAL VAL SEQRES 4 A 311 LEU ALA GLU ALA ILE GLY LEU ASP LYS ASP LYS PRO ASN SEQRES 5 A 311 ARG VAL THR LYS VAL ALA VAL LYS MET LEU LYS SER ASP SEQRES 6 A 311 ALA THR GLU LYS ASP LEU SER ASP LEU ILE SER GLU MET SEQRES 7 A 311 GLU MET MET LYS MET ILE GLY LYS HIS LYS ASN ILE ILE SEQRES 8 A 311 ASN LEU LEU GLY ALA CYS THR GLN ASP GLY PRO LEU TYR SEQRES 9 A 311 VAL ILE VAL GLU TYR ALA SER LYS GLY ASN LEU ARG GLU SEQRES 10 A 311 TYR LEU GLN ALA ARG ARG PRO PRO GLY LEU GLU TYR SER SEQRES 11 A 311 TYR ASN PRO SER HIS ASN PRO GLU GLU GLN LEU SER SER SEQRES 12 A 311 LYS ASP LEU VAL SER CYS ALA TYR GLN VAL ALA ARG GLY SEQRES 13 A 311 MET GLU TYR LEU ALA SER LYS LYS CYS ILE HIS ARG ASP SEQRES 14 A 311 LEU ALA ALA ARG ASN VAL LEU VAL THR GLU ASP ASN VAL SEQRES 15 A 311 MET LYS ILE ALA ASP PHE GLY LEU ALA ARG ASP ILE HIS SEQRES 16 A 311 HIS ILE ASP TYR TYR LYS LYS THR THR ASN GLY ARG LEU SEQRES 17 A 311 PRO VAL LYS TRP MET ALA PRO GLU ALA LEU PHE ASP ARG SEQRES 18 A 311 ILE TYR THR HIS GLN SER ASP VAL TRP SER PHE GLY VAL SEQRES 19 A 311 LEU LEU TRP GLU ILE PHE THR LEU GLY GLY SER PRO TYR SEQRES 20 A 311 PRO GLY VAL PRO VAL GLU GLU LEU PHE LYS LEU LEU LYS SEQRES 21 A 311 GLU GLY HIS ARG MET ASP LYS PRO SER ASN CYS THR ASN SEQRES 22 A 311 GLU LEU TYR MET MET MET ARG ASP CYS TRP HIS ALA VAL SEQRES 23 A 311 PRO SER GLN ARG PRO THR PHE LYS GLN LEU VAL GLU ASP SEQRES 24 A 311 LEU ASP ARG ILE VAL ALA LEU THR SER ASN GLN GLU SEQRES 1 B 311 GLY ALA MET SER GLY VAL SER GLU TYR GLU LEU PRO GLU SEQRES 2 B 311 ASP PRO ARG TRP GLU LEU PRO ARG ASP ARG LEU VAL LEU SEQRES 3 B 311 GLY LYS PRO LEU GLY GLU GLY ALA PHE GLY GLN VAL VAL SEQRES 4 B 311 LEU ALA GLU ALA ILE GLY LEU ASP LYS ASP LYS PRO ASN SEQRES 5 B 311 ARG VAL THR LYS VAL ALA VAL LYS MET LEU LYS SER ASP SEQRES 6 B 311 ALA THR GLU LYS ASP LEU SER ASP LEU ILE SER GLU MET SEQRES 7 B 311 GLU MET MET LYS MET ILE GLY LYS HIS LYS ASN ILE ILE SEQRES 8 B 311 ASN LEU LEU GLY ALA CYS THR GLN ASP GLY PRO LEU TYR SEQRES 9 B 311 VAL ILE VAL GLU TYR ALA SER LYS GLY ASN LEU ARG GLU SEQRES 10 B 311 TYR LEU GLN ALA ARG ARG PRO PRO GLY LEU GLU TYR SER SEQRES 11 B 311 TYR ASN PRO SER HIS ASN PRO GLU GLU GLN LEU SER SER SEQRES 12 B 311 LYS ASP LEU VAL SER CYS ALA TYR GLN VAL ALA ARG GLY SEQRES 13 B 311 MET GLU TYR LEU ALA SER LYS LYS CYS ILE HIS ARG ASP SEQRES 14 B 311 LEU ALA ALA ARG ASN VAL LEU VAL THR GLU ASP ASN VAL SEQRES 15 B 311 MET LYS ILE ALA ASP PHE GLY LEU ALA ARG ASP ILE HIS SEQRES 16 B 311 HIS ILE ASP TYR TYR LYS LYS THR THR ASN GLY ARG LEU SEQRES 17 B 311 PRO VAL LYS TRP MET ALA PRO GLU ALA LEU PHE ASP ARG SEQRES 18 B 311 ILE TYR THR HIS GLN SER ASP VAL TRP SER PHE GLY VAL SEQRES 19 B 311 LEU LEU TRP GLU ILE PHE THR LEU GLY GLY SER PRO TYR SEQRES 20 B 311 PRO GLY VAL PRO VAL GLU GLU LEU PHE LYS LEU LEU LYS SEQRES 21 B 311 GLU GLY HIS ARG MET ASP LYS PRO SER ASN CYS THR ASN SEQRES 22 B 311 GLU LEU TYR MET MET MET ARG ASP CYS TRP HIS ALA VAL SEQRES 23 B 311 PRO SER GLN ARG PRO THR PHE LYS GLN LEU VAL GLU ASP SEQRES 24 B 311 LEU ASP ARG ILE VAL ALA LEU THR SER ASN GLN GLU HET YY6 A 801 43 HET YY6 B 801 43 HET SO4 B 802 5 HETNAM YY6 7-(CYCLOHEXYLAMINO)-3-(2,6-DICHLORO-3,5- HETNAM 2 YY6 DIMETHOXYPHENYL)-1-{(3S)-1-[(2E)-4-(DIMETHYLAMINO)BUT- HETNAM 3 YY6 2-ENOYL]PYRROLIDIN-3-YL}-3,4-DIHYDROPYRIMIDO[4,5- HETNAM 4 YY6 D]PYRIMIDIN-2(1H)-ONE HETNAM SO4 SULFATE ION FORMUL 3 YY6 2(C30 H39 CL2 N7 O4) FORMUL 5 SO4 O4 S 2- FORMUL 6 HOH *54(H2 O) HELIX 1 AA1 PRO A 474 ASP A 476 5 3 HELIX 2 AA2 THR A 521 GLY A 539 1 19 HELIX 3 AA3 ASN A 568 ALA A 575 1 8 HELIX 4 AA4 SER A 596 LYS A 617 1 22 HELIX 5 AA5 ALA A 625 ARG A 627 5 3 HELIX 6 AA6 PRO A 663 MET A 667 5 5 HELIX 7 AA7 ALA A 668 ARG A 675 1 8 HELIX 8 AA8 THR A 678 THR A 695 1 18 HELIX 9 AA9 PRO A 705 GLU A 715 1 11 HELIX 10 AB1 THR A 726 TRP A 737 1 12 HELIX 11 AB2 VAL A 740 ARG A 744 5 5 HELIX 12 AB3 THR A 746 THR A 761 1 16 HELIX 13 AB4 PRO B 474 ASP B 476 5 3 HELIX 14 AB5 THR B 521 GLY B 539 1 19 HELIX 15 AB6 ASN B 568 ALA B 575 1 8 HELIX 16 AB7 SER B 596 LYS B 617 1 22 HELIX 17 AB8 ALA B 625 ARG B 627 5 3 HELIX 18 AB9 LEU B 662 ALA B 668 5 7 HELIX 19 AC1 PRO B 669 ARG B 675 1 7 HELIX 20 AC2 THR B 678 THR B 695 1 18 HELIX 21 AC3 PRO B 705 GLU B 715 1 11 HELIX 22 AC4 THR B 726 TRP B 737 1 12 HELIX 23 AC5 VAL B 740 ARG B 744 5 5 HELIX 24 AC6 THR B 746 THR B 761 1 16 SHEET 1 AA1 5 LEU A 478 GLY A 485 0 SHEET 2 AA1 5 GLN A 491 ILE A 498 -1 O VAL A 492 N LEU A 484 SHEET 3 AA1 5 VAL A 508 MET A 515 -1 O VAL A 511 N ALA A 495 SHEET 4 AA1 5 TYR A 558 GLU A 562 -1 O VAL A 561 N ALA A 512 SHEET 5 AA1 5 LEU A 547 CYS A 551 -1 N LEU A 548 O ILE A 560 SHEET 1 AA2 2 VAL A 629 VAL A 631 0 SHEET 2 AA2 2 MET A 637 ILE A 639 -1 O LYS A 638 N LEU A 630 SHEET 1 AA3 5 LEU B 478 GLU B 486 0 SHEET 2 AA3 5 GLN B 491 ILE B 498 -1 O VAL B 492 N GLY B 485 SHEET 3 AA3 5 VAL B 508 MET B 515 -1 O MET B 515 N GLN B 491 SHEET 4 AA3 5 TYR B 558 GLU B 562 -1 O VAL B 561 N ALA B 512 SHEET 5 AA3 5 LEU B 547 CYS B 551 -1 N GLY B 549 O ILE B 560 SHEET 1 AA4 2 VAL B 629 VAL B 631 0 SHEET 2 AA4 2 MET B 637 ILE B 639 -1 O LYS B 638 N LEU B 630 SITE 1 AC1 16 LEU A 484 VAL A 492 ALA A 512 LYS A 514 SITE 2 AC1 16 GLU A 531 VAL A 559 VAL A 561 GLU A 562 SITE 3 AC1 16 ALA A 564 GLY A 567 ASN A 568 GLU A 571 SITE 4 AC1 16 ALA A 640 ASP A 641 PHE A 642 HOH A 918 SITE 1 AC2 11 LEU B 484 LYS B 514 GLU B 531 VAL B 559 SITE 2 AC2 11 VAL B 561 GLU B 562 ALA B 564 GLU B 571 SITE 3 AC2 11 LEU B 630 ALA B 640 ASP B 641 SITE 1 AC3 3 LYS B 665 PRO B 702 GLY B 703 CRYST1 213.293 52.035 66.045 90.00 107.08 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.004688 0.000000 0.001440 0.00000 SCALE2 0.000000 0.019218 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015840 0.00000